Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 122

1.

Three-year experience with access to nationally funded growth hormone (GH) replacement for GH-deficient adults.

Holdaway IM, Hunt P, Manning P, Cutfield W, Gamble G, Ninow N, Staples-Moon D, Moodie P, Metcalfe S.

Clin Endocrinol (Oxf). 2015 Jul;83(1):85-90. doi: 10.1111/cen.12691. Epub 2015 Feb 9.

PMID:
25523467
2.

Comparison of two low-dose calcium infusion schedules for localization of insulinomas by selective pancreatic arterial injection with hepatic venous sampling for insulin.

Braatvedt G, Jennison E, Holdaway IM.

Clin Endocrinol (Oxf). 2014 Jan;80(1):80-4. doi: 10.1111/cen.12253. Epub 2013 Jun 20.

PMID:
23711285
3.

Mortality and morbidity in Cushing's syndrome in New Zealand.

Bolland MJ, Holdaway IM, Berkeley JE, Lim S, Dransfield WJ, Conaglen JV, Croxson MS, Gamble GD, Hunt PJ, Toomath RJ.

Clin Endocrinol (Oxf). 2011 Oct;75(4):436-42. doi: 10.1111/j.1365-2265.2011.04124.x.

PMID:
21609352
4.

Unmasking of undiagnosed pre-existing central diabetes insipidus after renal transplantation.

Kim DD, Holdaway IM.

Pituitary. 2012 Mar;15(1):106-9. doi: 10.1007/s11102-010-0259-y.

PMID:
20821268
5.

A meta-analysis of the effect of lowering serum levels of GH and IGF-I on mortality in acromegaly.

Holdaway IM, Bolland MJ, Gamble GD.

Eur J Endocrinol. 2008 Aug;159(2):89-95. doi: 10.1530/EJE-08-0267. Epub 2008 Jun 4.

PMID:
18524797
6.

Excess mortality in acromegaly.

Holdaway IM.

Horm Res. 2007;68 Suppl 5:166-72. doi: 10.1159/000110617. Epub 2007 Dec 10. Review.

PMID:
18174739
7.

Acute retinal pigment epitheliitis associated with intravenous bisphosphonate.

Gilhotra JS, Gilhotra AK, Holdaway IM, Donaldson ML.

Br J Ophthalmol. 2006 Jun;90(6):798-9. No abstract available.

8.

Serum IGF-I levels are similar in Samoan, Māori and European populations despite differences in body composition.

Bagg W, Aoina J, Cross PA, Whalley GA, Gamble GD, Doughty RN, Holdaway IM.

Growth Horm IGF Res. 2006 Feb;16(1):57-60. Epub 2006 Jan 23.

PMID:
16431147
9.

Treatment of acromegaly.

Holdaway IM.

Horm Res. 2004;62 Suppl 3:79-92. Review.

PMID:
15539805
10.

Factors influencing mortality in acromegaly.

Holdaway IM, Rajasoorya RC, Gamble GD.

J Clin Endocrinol Metab. 2004 Feb;89(2):667-74.

PMID:
14764779
11.

Oncogenic osteomalacia: culprit tumour detection whole body magnetic resonance imaging.

Dissanayake AM, Wilson JL, Holdaway IM, Reid IR.

Intern Med J. 2003 Dec;33(12):615-6. No abstract available.

PMID:
14656239
12.

Serum insulin-like growth factor-I and insulin-like growth factor binding protein-3 following chemotherapy for advanced breast cancer.

Holdaway IM, Mason BH, Lethaby AE, Singh V, Harvey VJ, Thompson PI, Evans BD.

ANZ J Surg. 2003 Nov;73(11):905-8.

PMID:
14616567
13.

An unusual cause of hyperinsulinaemic hypoglycaemia syndrome.

Manning PJ, Espiner EA, Yoon K, Drury PL, Holdaway IM, Bowers A.

Diabet Med. 2003 Sep;20(9):772-6.

PMID:
12925060
14.

Long-term treatment outcome in acromegaly.

Holdaway IM, Rajasoorya CR, Gamble GD, Stewart AW.

Growth Horm IGF Res. 2003 Aug;13(4):185-92. Review.

PMID:
12914751
15.

Melanocortin-3 receptor gene variants in a Maori kindred with obesity and early onset type 2 diabetes.

Wong J, Love DR, Kyle C, Daniels A, White M, Stewart AW, Schnell AH, Elston RC, Holdaway IM, Mountjoy KG.

Diabetes Res Clin Pract. 2002 Oct;58(1):61-71.

PMID:
12161058
16.

Elevated thyroid hormone levels with normal or raised thyroid-stimulating hormone: a diagnostic and therapeutic dilemma.

Holdaway IM.

Intern Med J. 2001 Sep-Oct;31(7):379-81. No abstract available.

PMID:
11584897
17.

Effect of breast surgery on serum levels of insulin-like growth factors (IGF-I, IGF-II, and IGF binding protein-3) in women with benign and malignant breast lesions.

Holdaway IM, Lethaby AE, Mason BH, Singh V, Harman JE, MacCormick M, Civil ID.

Ann Surg Oncol. 2001 Jan-Feb;8(1):25-31.

PMID:
11206220
18.

Epidemiology of acromegaly.

Holdaway IM, Rajasoorya C.

Pituitary. 1999 Jun;2(1):29-41. Review.

PMID:
11081170
19.

Comparison of an LH-RH analogue (Goeserelin acetate, 'Zoladex') with combined androgen blockade in advanced prostate cancer: final survival results of an international multicentre randomized-trial. International Prostate Cancer Study Group.

Tyrrell CJ, Altwein JE, Klippel F, Jurincic-Winkler C, Varenhorst E, Lunglmayr G, Boccardo F, Holdaway IM, Haefliger JM, Jordaan JP.

Eur Urol. 2000 Feb;37(2):205-11.

PMID:
10705200
20.

Height-related risk factors for prostate cancer.

Norrish AE, McRae CU, Holdaway IM, Jackson RT.

Br J Cancer. 2000 Jan;82(1):241-5.

21.

Serum levels of insulin-like growth factor binding protein-3 in benign and malignant breast disease.

Holdaway IM, Mason BH, Lethaby AE, Singh V, Harman JE, MacCormick M, Civil ID.

Aust N Z J Surg. 1999 Jul;69(7):495-500.

PMID:
10442920
22.

Seasonal variation in the secretion of mammotrophic hormones in normal women and women with previous breast cancer.

Holdaway IM, Mason BH, Gibbs EE, Rajasoorya C, Lethaby A, Hopkins KD, Evans MC, Lim T, Schooler B.

Breast Cancer Res Treat. 1997 Jan;42(1):15-22.

PMID:
9116314
23.

Characteristics of the menstrual cycle at the time of surgery for breast cancer.

Holdaway IM, Mason BH, Lethaby AE, Harman JE, France JT, Knox BS.

Br J Cancer. 1997;75(3):413-6.

24.

The case for growth hormone replacement in adult hypopituitarism.

Florkowski CM, Holdaway IM, Manning PJ, Donald RA.

N Z Med J. 1996 Sep 27;109(1030):349-51. Review. No abstract available.

PMID:
8890858
25.

Overall survival from breast cancer in women pregnant or lactating at or after diagnosis. Auckland Breast Cancer Study Group.

Lethaby AE, O'Neill MA, Mason BH, Holdaway IM, Harvey VJ.

Int J Cancer. 1996 Sep 17;67(6):751-5.

26.

Survival of women with node negative breast cancer in the Auckland region.

Lethaby AE, Mason BH, Harvey VJ, Holdaway IM.

N Z Med J. 1996 Sep 13;109(1029):330-3.

PMID:
8862351
27.

Measurement of human IGF-II using Sephacryl extraction: a rapid and reliable assay method.

Mason BH, Tatnell MA, Holdaway IM.

Ann Clin Biochem. 1996 May;33 ( Pt 3):201-8.

PMID:
8791982
28.

Effect of dexfenfluramine on body weight, blood pressure, insulin resistance and serum cholesterol in obese individuals.

Holdaway IM, Wallace E, Westbrooke L, Gamble G.

Int J Obes Relat Metab Disord. 1995 Oct;19(10):749-51.

PMID:
8589769
29.

Treatment of macroprolactinomas at Auckland Hospital 1975-91.

Wallace EA, Holdaway IM.

N Z Med J. 1995 Feb 22;108(994):50-2.

PMID:
7885646
30.

Effect of fosinopril on cardiac and metabolic parameters in patients with NIDDM.

Holdaway IM, Gamble GD, Sanders GA, Greaves SC, Ellis-Pegler EM, Sharpe N.

Diabetes Care. 1994 Dec;17(12):1476-9.

PMID:
7882821
31.

Hypopituitarism in a diabetic: a reminder of the Houssay phenomenon.

Wallace E, Holdaway IM.

Aust N Z J Med. 1994 Dec;24(6):729. No abstract available.

PMID:
7717930
32.

Acromegaly: factors affecting the long term outcome after surgical treatment.

Wrightson P, Rajasoorya C, Holdaway IM, Scott DJ.

J Clin Neurosci. 1994 Jul;1(3):164-72.

PMID:
18638755
33.

Determinants of clinical outcome and survival in acromegaly.

Rajasoorya C, Holdaway IM, Wrightson P, Scott DJ, Ibbertson HK.

Clin Endocrinol (Oxf). 1994 Jul;41(1):95-102.

PMID:
8050136
34.

Treatment of breast cancer in the Auckland region 1976-85.

Mason BH, Holdaway IM, Newman PD, Kay RG, Benjamin C, Harvey VJ.

N Z Med J. 1994 Mar 23;107(974):93-6.

PMID:
8127516
35.
36.

Multicenter randomized trial comparing Zoladex with Zoladex plus flutamide in the treatment of advanced prostate cancer. Survival update. International Prostate Cancer Study Group.

Tyrrell CJ, Altwein JE, Klippel F, Varenhorst E, Lunglmayr G, Boccardo F, Holdaway IM, Haefliger JM, Jordaan JP, Sotarauta M.

Cancer. 1993 Dec 15;72(12 Suppl):3878-9. No abstract available.

PMID:
8252508
37.

Parathyroid cyst with recurrent vocal cord paresis.

Grey AB, Shaw JH, Anderson NE, Holdaway IM.

Aust N Z J Surg. 1993 Jul;63(7):561-2. No abstract available.

PMID:
8317984
38.

Detection of contralateral breast cancer by mammography in women with previous breast cancer and the impact of endocrine therapy.

Mason BH, Holdaway IM, Benton NM, Benson-Cooper DM, Hadden WE, Kay RG.

N Z Med J. 1993 Feb 10;106(949):23-5.

PMID:
8464582
39.

Age and ethnicity as prognostic factors influencing overall survival in breast cancer patients in the Auckland region. Auckland Breast Cancer Study Group.

Lethaby AE, Mason BH, Holdaway IM, Kay RG.

N Z Med J. 1992 Dec 9;105(947):485-8. Erratum in: N Z Med J 1993 Apr 28;106(954):166.

PMID:
1461604
40.

Incidence and clinical features of breast cancer in the Auckland region.

Newman PD, Mason BH, Holdaway IM, Kay RG, Arthur JF, Hitchcock GC.

N Z Med J. 1992 Apr 8;105(931):117-20.

PMID:
1313956
41.

Insulin secretion and insulin-like growth factor-I levels in active and controlled acromegaly.

Hopkins KD, Holdaway IM.

Clin Endocrinol (Oxf). 1992 Jan;36(1):53-7.

PMID:
1559300
42.
43.
44.

Seasonal changes in serum melatonin in women with previous breast cancer.

Holdaway IM, Mason BH, Gibbs EE, Rajasoorya C, Hopkins KD.

Br J Cancer. 1991 Jul;64(1):149-53.

45.

Treatment of a patient with severe menstrual migraine using the depot LHRH analogue Zoladex.

Holdaway IM, Parr CE, France J.

Aust N Z J Obstet Gynaecol. 1991 May;31(2):164-5.

PMID:
1834050
46.

The acromegalic rosary.

Ibbertson HK, Manning PJ, Holdaway IM, Gamble G, Synek BJ.

Lancet. 1991 Jan 19;337(8734):154-6.

PMID:
1670798
47.

High peripheral and axial bone densities in a postmenopausal woman with untreated hypoparathyroidism.

Orr-Walker B, Harris R, Holdaway IM, Foote G, Reid IR.

Postgrad Med J. 1990 Dec;66(782):1061-3.

48.

Seasonal change in the concentration of progesterone receptor in breast cancer.

Holdaway IM, Mason BH, Marshall RJ, Neave LM, Kay RG.

Cancer Res. 1990 Sep 15;50(18):5883-6.

49.

Myocardial infarction is inversely associated with plasma 25-hydroxyvitamin D3 levels: a community-based study.

Scragg R, Jackson R, Holdaway IM, Lim T, Beaglehole R.

Int J Epidemiol. 1990 Sep;19(3):559-63.

PMID:
2262248
50.

Loss of insulin binding and insulin receptor mRNA in a transformed human fetal fibroblast cell line.

Mountjoy KG, Moller DE, Flier JS, Holdaway IM.

Biochem Biophys Res Commun. 1990 Jun 29;169(3):978-85.

PMID:
1973037

Supplemental Content

Loading ...
Support Center